Heparin inhibits the inflammatory response induced by LPS and HMGB1 by blocking the binding of HMGB1 to the surface of macrophages

Cytokine. 2015 Mar;72(1):36-42. doi: 10.1016/j.cyto.2014.12.010. Epub 2015 Jan 3.

Abstract

High mobility group box 1 protein (HMGB1), a nuclear non-histone DNA-binding protein, is secreted extracellularly during inflammation and is a late mediator of inflammatory responses. The pro-inflammatory activity of recombinant HMGB1 proteins is dependent upon the formation of complexes with other mediators, such as lipopolysaccharide (LPS). This study investigated the influence of heparin on LPS+HMGB1-mediated inflammatory responses in cultured macrophages and a murine sepsis model. HMGB1 promoted the phosphorylation of p38 and ERK1/2. HMGB1 enhanced the induction of the pro-inflammatory cytokine, TNF-α, by LPS in macrophages. Heparin blocked the binding of HMGB1 to the surface of macrophages, and suppressed the phosphorylation of p38 and ERK1/2, but not JNK; TNF-α secretion was also decreased. However, heparin alone did not affect LPS-induced production of TNF-α. Heparin reduced lethality in mice exposed to LPS+HMGB1. To conclude, heparin inhibited LPS-induced HMGB1-amplified inflammatory responses by blocking HMGB1 binding to macrophage surfaces. Heparin could be used therapeutically as an effective inhibitor of HMGB1-associated inflammation.

Keywords: Heparin; High mobility group box 1 protein; Lipopolysaccharide; Mitogen-activated protein kinase; Tumour necrosis factor-α.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Disease Models, Animal
  • Enzyme Activation
  • HMGB1 Protein / metabolism*
  • Heparin / pharmacology*
  • Inflammation / immunology
  • Lipopolysaccharides / immunology
  • MAP Kinase Signaling System / drug effects
  • Macrophages / drug effects*
  • Macrophages / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Phosphorylation / drug effects
  • Sepsis / drug therapy*
  • Sepsis / immunology
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • HMGB1 Protein
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Heparin
  • Mitogen-Activated Protein Kinase 3